How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

How Much Control Do We Really Have Over Our Health? Spermidine, Autophagy and Patient Empowerment

At 39, Leslie Kenny was diagnosed with rheumatoid arthritis and lupus and says she was told she had around five years to live. More than two decades later, she is in long-term remission and has turned that experience into a mission: helping patients become better informed, more involved and more confident in decisions about their own health.

In this episode, Leslie Kenny, founder of Oxford Healthspan and co-founder of the Oxford Longevity Project, joins Daphna Stern to tell the story of how she challenged her original prognosis, found intravenous immunoglobulin (IVIG) through her own research, changed her diet and ultimately reached remission.

But her story also raises a much bigger question: where should patient empowerment end and medical expertise begin?

The conversation then turns to spermidine, a naturally occurring compound found in the body and in foods that has attracted growing interest for its relationship with autophagy — the cellular recycling process that helps remove and reuse damaged cellular material. Leslie explains why she became convinced of its potential and why she believes natural compounds such as spermidine struggle to attract the research funding available to patentable drugs.

Daphna also pushes on the evidence. How much do we actually know about spermidine in humans? What can observational studies tell us — and what can they not? How does the evidence compare with interventions such as rapamycin? And when does an intriguing longevity molecule become something we can genuinely recommend?

The conversation expands beyond supplements into a broader discussion about personal responsibility for health, the exposome, the future of preventative medicine and what healthcare could look like if it focused not simply on extending life, but on helping people live well for longer — right through to the end.

Guest Bio

Leslie Kenny is the founder of Oxford Healthspan and co-founder of the Oxford Longevity Project. Diagnosed with rheumatoid arthritis and lupus at 39 and given a five-year prognosis, Kenny used patient research, dietary overhaul, and an experimental immunoglobulin therapy to reverse her condition into long-term remission. She trained at the Institute for Integrative Nutrition and now serves as Global Executive Ambassador for the Japan Autophagy Consortium. Through Oxford Healthspan, she develops food-derived spermidine and nettle-based nutraceuticals, and through the Oxford Longevity Project, she works alongside scientists including Sir Muir Gray, Sir Christopher Ball, Dr Paul Chen, and Emeritus Professor Dennis Noble to advance patient-centred ageing research.

LinkedIn: https://www.linkedin.com/in/leslie-kenny-oxford/

Timestamps

* 00:00 — Introduction to Leslie Kenny and her story

* 02:10 — IVF, autoimmune disease and the diagnosis that changed everything

* 04:30 — Questioning the original diagnosis and discovering a thyroid problem

* 08:15 — How patient research led Leslie to intravenous immunoglobulin (IVIG)

* 13:00 — Diet, elimination protocols and visualisation

* 17:40 — Reaching remission and turning personal experience into advocacy

* 21:50 — How to challenge your doctor without rejecting conventional medicine

* 25:30 — What spermidine is and why Leslie became interested in it

* 29:15 — Spermidine, the hallmarks of ageing and the comparison with rapamycin

* 34:00 — Why natural compounds can struggle for funding, patents and attention

* 38:20 — What the human evidence for spermidine actually tells us

* 43:10 — The funding problem in independent longevity research

* 45:30 — Oxford Healthspan and the Oxford Longevity Project

* 48:00 — How much control do we really have over our health and ageing?

* 52:00 — Rethinking hospitals, later life and what a good death looks like

* 56:30 — Rapid-fire questions

* 59:00 — Closing reflections

References & Further Reading

  • Kenny, L. — founder, Oxford Healthspan
  • Oxford Longevity Project (co-founded with Sir Muir Gray, Sir Christopher Ball, Dr. Paul Chen, Prof. Dennis Noble)
  • Sears, B. — The Anti-Aging Zone
  • Franceschi, C. — originator of the "inflammaging" concept
  • Partridge, L., Madeo, F., Kennedy, B. — research on spermidine and the hallmarks of ageing
  • Eisenberg, T., et al. — Grazer study on spermidine and human cell telomeres (2021)

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(37)

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Can You Do Too Much for Your Health? Biological Age, NAD+ and Longevity Hype

Longevity medicine has created a strange new kind of patient: the healthy person convinced something must be wrong.A wearable flags poor recovery. One test says your body is ageing faster than it shou...

20 Syys 1h

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

Can a Supplement Actually Slow Ageing? NOVOS Founder Chris Mirabile on Tackling All 12 Hallmarks

At 16, Chris Mirabile was lying in a hospital bed the night before brain surgery, wondering whether he would wake up the next morning. Years later, as he was building NOVOS, he lost his mother to panc...

13 Syys 1h 14min

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Beyond Longevity at HLTH Europe Part Two: Microbiomes, Breath Diagnostics and the Future of Medical AI

Recorded at HLTH Europe in Amsterdam, Part Two of our special series looks at four very different ways technology could help healthcare move earlier, become more personalised and make better use of th...

6 Syys 57min

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

Beyond Longevity at HLTH Europe: Wearables, AI and Remote Rehabilitation for Preventive Health

What happens when technology stops simply tracking our health and starts helping us understand what to do about it?Recorded at HLTH Europe in Amsterdam, this episode of Beyond Longevity features three...

30 Elo 42min

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

Can a Senolytic Vaccine Slow Ageing? Dr David Scieszka on Senescent Cells and Longevity

What if a vaccine could help the immune system clear senescent “zombie” cells — damaged cells linked to ageing, chronic inflammation and age-related disease?In this episode of Beyond Longevity, Daphna...

23 Elo 56min

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

Can One Drug Slow Ageing Across the Whole Body? LinkGevity’s Bid to Block Necrosis

What if heart disease, kidney disease and dementia share a common mechanism linked to ageing? And what if blocking a destructive form of cell death called necrosis could help protect several organs at...

16 Elo 1h 6min

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

The Hardest Problem in Longevity Is Human Behaviour with Dr Gil Blander, Founder of InsideTracker

Nearly two decades ago, Dr Gil Blander was trying to convince investors of an idea that, at the time, sounded radical: blood biomarkers should not only be used to diagnose disease, but to help healthy...

2 Elo 48min

Suosittua kategoriassa Tiede

rss-mita-tulisi-tietaa
rss-poliisin-mieli
utelias-mieli
rss-hereilla
tiedekulma-podcast
rss-duodecim-lehti
rss-luontopodi-samuel-glassar-tutkii-luonnon-ihmeita
hippokrateen-vastaanotolla
rss-bios-podcast
docemilia
rss-politiikasta-podcast
rss-tiedetta-vai-tarinaa
rss-ranskaa-raakana
rss-lihavuudesta-podcast
radio-antro
rss-radplus